One of the first lessons I learned in investing is to never blindly follow anyone, no matter how knowledgeable they appear to be and regardless of the strength of their track record. Everyone is wrong from time to time, even the best investors. In… More
A one drug company with a negative FDA panel recomendation = NO approval and a plummeting price
The Phase III had a fatal incident and and was not even conducted with the most at risk (and most probable potential customer). In light of the FDA's… More